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Background/aim: Vitamin D, adropin, proinflammatory cytokines, and oxidative stress closely related with metabolic homeostasis
and endothelial dysfunction. The aim of the present study is to investigate how vitamin D levels affect serum adropin, IL-1ß, IL-6, and
oxidative stress.
Materials and methods: A total of 77 female subjects were divided into 3 groups according to vitamin D levels. Biochemical parameters,
adropin, IL-1ß, IL-6, oxidative stress markers were studied in these groups, and the results were compared statistically.
Results: Serum adropin, IL-1ß, IL-6, total oxidant status (TOS) and total antioxidant status (TAS) and oxidative stress index (OSI) levels
differed significantly between the vitamin D groups (p < 0.05). A significant positive correlation was detected between vitamin D, and
adropin and TAS (r = 0.807; p < 0.001, r = 0.814; p < 0.001, respectively). A significant negative correlation was detected between vitamin
D, and IL-1ß, IL-6, TOS, OSI (r = –0.725; p < 0.001, r = –0.720; p < 0.001, r = –0.238; p = 0.037, r = –0.705; p < 0.001, respectively).
Conclusions: Vitamin D could show its effects through vitamin D receptors on tissues or on the ENHO gene in adropin secreting tissues
via direct or indirect mechanisms. Proinflammatory cytokines, oxidative stress, and adropin targeted studies could contribute to the
prevention and treatment of diseases associated with vitamin D deficiency in future.
Key words: Vitamin D, adropin, IL-1 beta, IL-6, oxidative stress

1. Introduction
While vitamin D is mainly synthesized in the skin under
the influence of sunlight in humans, a small portion
is obtained from foods. Vitamin D mainly regulates
calcium, phosphorus and bone metabolism, and is
also known as an immunomodulator hormone [1–3].
Vitamin D deficiency might be due to factors including
poor sunlight exposure, insufficient intake of vitamincontaining foods and malabsorption syndromes (Crohn’s
disease and Celiac disease). Vitamin D has been shown
to exert its physiological effects via vitamin D receptors
(VDR) present in many tissues and organs [1,4]. Being
a worldwide health issue, vitamin D deficiency and
insufficiency was associated with many illnesses including
osteoporosis, metabolic syndrome, cardiovascular
diseases, diabetes, hypertension, endothelial dysfunction,
infectious diseases, autoimmune disorders, cancers, and
neurological disorders [1,2,5].

Adropin is a peptide hormone coded by the energy
homeostasis-associated gene (ENHO) mainly in the
liver and brain. It is closely related to glucose and lipid
homeostasis and insulin resistance. It is produced in many
tissues and organs such as the liver, brain, heart, kidney,
pancreas, and gastrointestinal system [6–9]. Adropin has
been determined to increase NO release by stimulating
endothelial nitric oxide synthase (eNOS) via the interactions
between intracellular pathways, improving endothelial cell
functions, and protecting the cardiovascular system by
providing neovascularization [7,10]. Many studies have
reported that serum adropin levels might be associated with
obesity, diabetes mellitus, hypertension, cardiovascular
diseases, endothelial dysfunction, metabolic syndrome,
and several cancers [10–13].
Oxidative stress (OS) is a result of impaired balance
between the reactive oxygen species (ROS) formation
and antioxidant defense mechanisms. Free radical
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production occurs continuously in all cells as a part
of normal cellular functioning. High amounts of free
radicals and ROS formed in tissues due to OS interact
with intracellular molecules and cause cellular damage by
injuring various biological molecules including proteins,
lipids, and nucleic acids [14,15]. Excessive endogenous
or exogenous free radical production might have a role in
many illnesses. Antioxidants prevent free radical-induced
tissue damage by preventing the production of or removing
the free radicals. While total oxidant status (TOS) reflects
the total effect of all oxidants present in plasma and body
fluids, total antioxidant status (TAS) reflects the total
effect of all antioxidants. Measurement of TOS or TAS is
preferred to individual measurements of serum (or plasma)
concentrations of different oxidant or antioxidant molecules
[16,17]. OS increase leads to the development of metabolic
syndrome, endothelial dysfunction, hypertension, diabetes
mellitus, cardiovascular diseases, cancer, and kidney and
neurological diseases [14,15,18–21].
Interleukin-1 beta (IL-1β) and interleukin-6 (IL-6)
are proinflammatory cytokines especially produced by
myelomonocytic cells such as monocytes, macrophages,
and dendritic cells. They can be the pathogenic precursor
to autoinflammatory, autoimmune, infectious, and
degenerative diseases by affecting many cells and organs
[22,23]. Moreover, they are associated with endothelial
dysfunction, metabolic syndrome, insulin resistance,
hypertension, diabetes mellitus, oxidative stress, and
cardiovascular diseases [18,24–26].
Many chronic illnesses including endothelial dysfunction,
diabetes mellitus, cardiovascular diseases, malignancy,
autoimmune disorders which, as shown in the studies, were
associated with vitamin D were also similarly associated
with adropin, IL-1β, IL-6 and oxidative stress. In the
literature search we performed, there were limited number
of studies individually evaluating the relationship between
vitamin D level, and oxidative status or proinflammatory
cytokines (IL-1β,IL-6) in some diseases, however, there was
no study evaluating the relationship between vitamin D and
adropin or evaluating these parameters together. We aimed
to evaluate the relationship between the levels of vitamin
D and adropin, IL-1β, IL-6 and oxidative status, which, we
think might affect the pathological and metabolic conditions
seen in vitamin D deficiency.
2. Materials and methods
2.1. Study group
This cross-sectional, case-controlled trial was initiated
after approval of Bezmialem Foundation University, ethics
committee. Our study included 77 female subjects aged
18 to 65 years who consulted to Bezmialem Foundation
University, Internal Diseases Outpatient Clinic between
July 2020 and December 2020, did not have a known
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history of chronic illness, were not pregnant or lactating,
did not have a history of surgical operation within the last
6 months, did not use antioxidant medication, vitamin
supplement, lipid-lowering agent, tobacco or alcohol, did
not use vitamin D within the last 3 months, did not do
heavy exercise recently and have normal C-reactive protein
(CRP) levels. All study subjects gave written informed
consent. The subjects were divided into three groups
by their vitamin D level (G1: Vitamin D < 20 ng/mL,
deficiency; G2: Vitamin D = 20–30 ng/mL, insufficiency;
G3: Vitamin D > 30 ng/mL, normal) [5].
2.2. Blood assay
Venous blood samples were taken from all subjects into
gel tubes between 8:00 a.m. and 9:00 a.m. following 12 h of
fasting for biochemical parameters, adropin, TAS, TOS, IL-1β
and IL-6 tests, and centrifuged at 3600 rpm for 10 min and the
sera were separated. The sera of all subjects were transferred
into Eppendorf tubes and kept at –80 °C until the study day.
All volunteers underwent a thorough physical
examination with their height and weight being recorded.
Weight and height were rounded to the nearest kg and cm,
respectively, and body mass index (BMI) was calculated [BMI
= weight/(height)2].
2.2.1. Measurement of total antioxidant status and total
oxidant status (TAS and TOS) in serum
Total oxidant status and total antioxidant status were
determined by a recently developed method, colorimetric
assay [16]. The TAS results are expressed in mmol Trolox
Equiv./L., and TOS in μmol H2O2 Equiv./L. Coefficients of
variation values were less than 10%.
2.2.2. Oxidative stress index (OSI) determination
OSI was determined as TOS/TAS ratio (resulting TAS unit
was changed to μmol/L) and calculated as follows: OSI
(arbitrary unit) = TOS, μmol H2O2 Equiv./L/TAS, and mmol
Trolox Equiv./L [27].
2.2.3. Measurement of Adropin, IL-1β, and IL-6
Concentrations of adropin, IL-1β, and IL-6 in the serum
were measured by a specific commercial ELISA kit
according to the manufacturer’s instructions (Adropin:
E3231Hu, IL-1β: E0143Hu, IL-6: E0090Hu–Bioassay
Technology Laboratory, China). Concentrations were
determined with a spectrophotometric microtiter plate
reader (Varioskan Flash Multimode Reader, Thermo,
Waltham, USA) at 450 nm optical density [27].
2.3. Statistical analysis
IBM SPSS (Statistical Package for Social Sciences) statistics
22.0 software was used for the statistical analyses for the
study. While evaluating the study data, descriptive statistical
methods (mean, standard deviation, median, frequency)
were used. Skewness and kurtosis values were used
together with the Shapiro-Wilk test to evaluate the normal
distribution of the data. While the one-way ANOVA test
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was used to compare more than two normally distributed
variables, the Kruskal Wallis test was used to evaluate
more than two nonnormally distributed variables. Tukey
and Games Howell tests were used for post-hoc pairwise
comparison of the parameters that were significant after
ANOVA and the Kruskal Wallis test. For the assessment of
correlation between the data, Pearson’s correlation analysis
was used for the normally distributed data and Spearman’s
correlation analysis for the nonnormally distributed data.
Results were evaluated within a 95% confidence interval
with significance at a p level of <0.05.
3. Results
The mean age of the 77 women participating in the study
was 33.79 ± 10.15 years and the mean BMI (body mass
index) was 24.90 ± 5.20 kg/m2. The mean age of the groups
that we divided into three groups according to their vitamin
D levels (G1: Vitamin D < 20 ng/mL; G2:Vitamin D 20–30
ng/mL; G3:Vitamin D > 30 ng/mL) was G1:32.35 ± 10.67,
G2:35.14 ± 10.85, and G3:35.41 ± 7.84 were determined. The
mean BMI of the three groups was G1:24.41 ± 5.26, G2:26.70
± 5.79, and G3:23.79 ± 3.81. There was no statistically
significant difference between the groups in terms of age
and BMI (p: 0.459, p: 0.163, respectively) (Table 1).

There was no statistically significant difference between
three groups in terms of glucose, creatinine, alanine
aminotransferase (ALT), aspartate aminotransferase (AST),
total cholesterol (TC), triglyceride (TG), low-density
lipoprotein-cholesterol (LDL-C), high-density lipoproteincholesterol (HDL-C), alkaline phosphatase (ALP), gamma
glutamyl transferase (GGT), calcium, magnesium,
phosphorus, thyroid stimulating hormone (TSH) and free
tetraiodothyronine (fT4) (p ˃ 0.05). As for adropin, IL-1β,
IL-6, TOS, TAS, OSI, and parathyroid hormone (PTH)
levels, a statistically significant difference was detected
between the groups (p ˂ 0.05) (Table 1).
In the correlation assessment between vitamin D, and
age, BMI, adropin, IL-1β, IL-6, TOS, TAS, OSI and other
biochemical parameters, significant positive correlation
was detected between vitamin D, and adropin and TAS (r =
0.807; p < 0.001, r = 0.814; p < 0.001, respectively). Significant
negative correlation was detected between vitamin D, and
IL-1β, IL-6, TOS, OSI and PTH (r = –0.725; p < 0.001, r =
–0.720; p < 0.001, r = –0.238; p = 0.037, r = –0.705; p < 0.001,
r = –0.524; p < 0.001, respectively) (Table 2). Evaluation of
the correlation between vitamin D and adropin, IL-1β, IL-6,
TOS, TAS and OSI is shown in Figures 1–6.

Figure 1. Correlation assessment between vitamin D level, and IL-1β level (n = 77,
total subjects). r: Correlation coefficient; IL-1β: Interleukin-1 beta.

Figure 2. Correlation assessment between vitamin D level and
IL-6 level (n = 77, total subjects). r: Correlation coefficient; IL-6:
Interleukin-6.

Figure 3. Correlation assessment between vitamin D level and
adropin level (n = 77, total subjects). r: Correlation coefficient.

Figure 4. Correlation assessment between vitamin D level and
TAS level (n = 77, total subjects). r: Correlation coefficient; TAS:
Total antioxidant status.
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In the correlation assessment between adropin,
and vitamin D, IL-1β, IL-6, TOS, TAS, OSI and PTH,
statistically significant positive correlation was detected
between adropin and TAS (r = 0.753; p < 0.001), and
statistically significant negative correlation was detected

between adropin, and IL-1β, IL-6, TOS, OSI and PTH
(r = –0.586; p < 0.001, r = –0.659; p < 0.001, r = –0.292;
p < 0.010, r = –0.673; p < 0.001, r = –0.511; p < 0.001,
respectively) (Table 3). Additionally, comparison of posthoc analyzes and paired groups is shown in Table 4.

Table 1. Comparison of age, BMI, adropin, IL-1β, IL-6, TOS, TAS, OSI and biochemical parameters of the vitamin D groups.

Group 1
Vitamin D
˂20 ng/mL
n = 39
Mean ± SD

Group 2
Vitamin D
20–30 ng/mL
n = 21
Mean ± SD

Group 3
Vitamin D
˃30 ng/mL
n = 17
Mean ± SD

p

Age (years)

32.35 ± 10.67

35.14 ± 10.85

35.41 ± 7.84

0.459

BMI (kg/m )

24.41 ± 5.26

26.70 ± 5.79

23.79 ± 3.81

0.163

Adropin (ng/L)

64.34 ± 19.08

109.92 ± 37.81

159.35± 38.65

<0.001*

IL-1β (pg/L)

469.65 ± 67.36

326.67 ± 64.32

268.20 ± 35.25

<0.001*

IL-6 (ng/L)

143.98 ± 19.46

104.23 ± 12.74

77.41 ± 15.57

<0.001*

TOS (μmol)

14.14 ± 1.11

13.95 ± 1.63

13.08 ± 1.66

0.037*

TAS (mmol)

0.89 ± 0.10

1.13 ± 0.11

1.26 ± 0.12

<0.001*

OSI (AU)

15.95 ± 2.25

12.59 ± 2.69

10.53 ± 2.42

<0.001*

Glucose (mg/dL)

91.41 ± 6.52

91.52 ± 6.75

88.47 ± 5.37

0.240

Creatinine (mg/dL)

0.70 ± 0.68

0.71 ± 0.52

0.72 ± 0.50

0.770

AST (U/L)

17.59 ± 6.51

18.57 ± 5.18

17.11 ± 4.15

0.716

ALT (U/L)

16.12 ± 9.48

17.95 ± 9.54

15.47 ± 8.47

0.677

ALP (U/L)

62.25 ± 18.40

56.95 ± 17.99

61.94 ± 23.94

0.586

GGT (U/L)

16.59 ± 11.38

15.38 ± 7.59

14 ± 4.71

0.626

TCholesterol (mg/dL)

179.87 ± 43.13

185.38 ± 34.32

195.94 ± 46.03

0.417

Triglyceride (mg/dL)

80.69 ± 43.70

74 ± 28.13

70.52 ± 23.55

0.585

LDL-C (mg/dL)

105.10 ± 33.83

104.37 ± 29.34

119.75 ± 36.22

0.269

HDL-C(mg/dL)

58.33 ± 11.58

64.37 ± 12.95

59.71 ± 17.37

0.252

Ca (mg/dL)

9.42 ± 0.39

9.34 ± 0.40

9.42 ± 0.33

0.743

P (mg/dL)

3.64 ± 0.57

3.59 ± 0.35

3.59 ± 0.39

0.886

Mg (mg/dL)

1.95 ± 0.14

1.92 ± 0.11

1.94 ± 0.13

0.757

PTH (ng/L)

68 ± 19.57

55.16 ± 20.19

38.16 ± 7.11

<0.001*

TSH (mU/L)

1.78 ± 0.94

1.53 ± 0.52

1.43 ± 0.51

0.216

FT4 (pg/mL)

12.38 ± 1.19

12.37 ± 1.40

12.37 ± 0.83

0.999

2

Mean ± SD: Mean ± standard deviation; BMI: Body mass index; IL-1β: Interleukin-1 beta; IL-6: Interleukin-6; TOS: Total oxidant
status; TAS: Total antioxidant status; OSI: Oxidative stress index; AU: Arbitrary unit; AST: Aspartate aminotransferase; ALT:
Alanine aminotransferase; ALP: Alkaline phosphatase; GGT: Gamma glutamyl transferase; TCholesterol: Total Cholesterol;
LDL-C: Low-density lipoprotein Cholesterol; HDL-C: High density lipoprotein Cholesterol; Ca: Calcium; P: Phosphorus; Mg:
Magnesium; PTH: Parathormone; TSH: Thyroid stimulating hormone; FT4: Free tetraiodothyronine; *Statistical significance (p
<0.05).
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Figure 5. Correlation assessment between vitamin D level and
TOS level (n = 77, total subjects). r: Correlation coefficient; TOS:
Total oxidant status.

Figure 6. Correlation assessment between vitamin D level and
OSI level (n = 77, total subjects). r: Correlation coefficient; OSI:
Oxidative stress index.

Table 2. Correlation assessment between vitamin D, and age, BMI, adropin, IL-1β, IL-6, TOS, TAS, OSI and biochemical parameters (n
= 77, total subjects).
r

p

Age (years)

–0.006

0.958

BMI (kg/m )

–0.064

0.581

Adropin (ng/L)

0.807

<0.001*

IL-1β (pg/L)

–0.725

<0.001*

IL-6 (ng/L)

–0.720

<0.001*

TOS (μmol)

–0.238

0.037*

TAS (mmol)

0.814

<0.001*

OSI (AU)

–0.705

<0.001*

PTH (ng/L)

–0.524

<0.001*

Calcium (mg/dL)

0.015

0.894

2

r: Correlation coefficient; BMI: Body mass index; IL-1β: Interleukin-1 beta; IL-6: Interleukin-6; TOS: Total oxidant status; TAS: Total
antioxidant status; OSI: Oxidative stress index; AU: Arbitrary unit; PTH: Parathormone; *Statistical significance (p <0.05).

Table 3. Correlation assessment between adropin level, and Vitamin D, IL-1β, IL-6, TOS, TAS, OSI and biochemical parameters (n =
77, total subjects).
R

p

Vitamin D

0.807

<0.001*

IL-1β (pg/L)

–0.586

<0.001*

IL-6 (ng/L)

–0.659

<0.001*

TOS (μmol)

–0.292

0.010*

TAS (mmol)

0.753

<0.001*

OSI (AU)

–0.673

<0.001*

PTH (ng/L)

–0.511

<0.001*

r: Correlation coefficient; IL-1β: Interleukin-1 beta; IL-6: Interleukin-6; TOS: Total oxidant status; TAS: Total antioxidant status; OSI:
Oxidative stress index; AU: Arbitrary unit; PTH: Parathormone; *Statistical significance (p < 0.05).
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Table 4. Comparison of post-hoc analyzes and pairwise groups.
G1

G2

G3

G1 vs. G2

G1 vs. G3

G2 vs. G3

Vitamin D ˂ 20 ng/
mL
n: 39
Mean ± SD

Vitamin D 20–30 ng/
mL
n: 21
Mean ± SD

Vitamin D >30 ng/
mL
n: 17
Mean ± SD

P Values

P values

P values

Adropin (ng/L) 64.34 ± 19.08

109.92 ± 37.81

159.35 ± 38.65

<0.001

<0.001

<0.001

IL-1 β (pg/L)

469.65 ± 67.36

326.67 ± 64.32

268.20 ± 35.25

<0.001

<0.001

0.012

IL-6 (ng/L)

143.98 ± 19.46

104.23 ± 12.74

77.41 ± 15.57

<0.001

<0.001

<0.001

TOS (μmol )

14.14 ± 1.11

13.95 ± 1.63

13.08 ± 1.66

0.868

0.030

0.148

TAS (mmol )

0.89 ± 0.10

1.13 ± 0.11

1.26 ± 0.12

<0.001

<0.001

0.001

OSI (AU)

15.95 ± 2.25

12.59 ± 2.69

10.53 ± 2.42

<0.001

<0.001

0.029

G1: Group 1, Vitamin D ˂ 20 ng/mL; G2: Group 2, Vitamin D 20–30 ng/mL; G3: Group 3, Vitamin D > 30 ng/mL; IL-1β: Interleukin-1
beta; IL-6: Interleukin-6; TOS: Total oxidant status; TAS: Total antioxidant status; OSI: Oxidative stress index; AU: Arbitrary unit;
*Statistical significance (p < 0.05).

4.Discussion
While vitamin D is mainly synthesized in the skin under
the influence of sunlight in humans, a small portion
is obtained from foods. Vitamin D mainly regulates
calcium, phosphorus and bone metabolism, and is also
known as an immunomodulator hormone [1–3]. In the
literature search, we did not find any study evaluating the
relationship between vitamin D level and adropin level.
Our study detected significant difference between
the vitamin D groups (G1, G2, G3) in terms of adropin
level, and also, a significant positive correlation between
vitamin D level and adropin level (p < 0.001). Adropin
has been reported to have lipid and glucose homeostasisregulating, angiogenesis and antiinflammatory effects in
addition to preventive effects against insulin resistance and
endothelial dysfunction [6,9,10,28,29]. Lovren et al. stated
that adropin might have a role in controlling the functions
of endothelial cells and protecting the endothelial cells
against TNFα-induced apoptosis. They explained this
effect of adropin by NOS increase due to increased
expression of eNOS via vascular endothelial growth factor
receptor (VEGFR2)-phosphatidylinositol 3-kinase-Akt
(PI3K-Akt) or VEGFR2-extracellular signal-regulated
kinase 1/2 (ERK 1/2) intracellular signal transmission
pathways [7,10]. In their study comparing serum adropin
levels of a total of 116 type 2 diabetes mellitus (T2DM)
patients and 60 control subjects with normal glucose
tolerance, Zang H. et al. detected that serum adropin level
is lower in T2DM patients, and especially in overweight/
obese individuals (compared to the group with normal
weight). In the study, it was stated that adropin which is
related with glucolipid homeostasis and insulin sensitivity
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might have a role in the pathogenesis of T2DM [30]. Topuz
M et al. compared the serum adropin levels of the groups
of subjects with or without endothelial dysfunction using
brachial flow-mediated dilation in patients with T2DM.
Serum adropin level was detected to be significantly lower
in subjects with endothelial dysfunction compared to
controls, and it was stated that low adropin level might be
a marker of endothelial dysfunction [29]. Plasma adropin
levels of individuals with primary hypertension and
normotensive individuals were studied in another study.
Plasma adropin levels were detected to be significantly
lower in the hypertensive group compared to controls, and
it was stated that low adropin level might be associated
with hypertension [31]. In their study of two groups
consisting of individuals with and without CAD, Zhang
C et al. found that serum adropin levels are significantly
lower in the CAD group compared to controls [32]. Similar
to the studies in the literature, in our study, we believe
that low serum adropin levels observed in subjects with
vitamin D deficiency might trigger the development and
progression of endothelial dysfunction, insulin resistance,
hypertension and cardiovascular diseases. We believe
that the low adropin level in vitamin D deficiency might
be caused by the stimulation level of vitamin D receptors
in tissues synthesizing adropin and vitamin D affecting
the expression of ENHO gene via direct or indirect
mechanisms. More studies are needed to illuminate these
possible mechanisms.
In our study, significant difference was detected
between vitamin D groups in terms of IL-1β and IL-6
levels, and also a significant negative correlation between
vitamin D level, and IL-1β and IL-6 levels (p ˂ 0.001).
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Proinflammatory cytokines (IL-1β, IL-6) have multiple
effects on many events including the initiation and
maintenance of inflammation, endothelial dysfunction,
metabolic syndrome, insulin resistance, diabetes mellitus,
oxidative stress and cardiovascular events [18,24–26]. It
has been stated that vitamin D might play an important
role in the modulation of immune/inflammation system
by regulating the production of inflammatory cytokines
and inhibiting the proliferation of the proinflammatory
cells [33]. In their study comparing coronary heart
disease (CHD) patients with their control subjects, Liu
Y et al. found that vitamin D level is significantly low
in CHD, and detected a significant negative correlation
between vitamin D, and IL-1β and IL-6. It has been stated
that vitamin D deficiency might induce and aggravate
CHD by increasing inflammation via NF-κB [34]. In
their study on 60 healthy controls and 106 (59 males, 47
females) T2DM patients, Wang W et al. divided T2DM
patients into three groups by vitamin D levels (Vitamin
D ≤ 20 ng/mL, 20–30 ng/mL and ≥30 ng/mL). They
detected that vitamin D level is considerably lower in
T2DM patients compared to healthy controls, and has
a negative correlation with IL-1β and IL-6 [35]. On the
other hand, in their study in healthy women, Azizieh F.
et al. divided the participants into 2 groups by vitamin D
levels [as >25 nmol/L (10 ng/mL) and <25 nmol/L]. They
did not detect a direct significant relationship between
serum vitamin D level, and inflammatory markers, IL1β and IL-6 [36]. Moreover, Peterson C. A. et al. did not
detect a significant relationship and correlation between
vitamin D concentrations and IL-6 in women exposed
to ultraviolet light (UVB) and divided into two groups
as high and low vitamin D level [37]. In their study in
type 2 diabetic patients, El Hajj C. et al. did not detect
a significant decrease in IL-6 levels following vitamin D
replacement treatment compared to prereplacement levels
[38]. The results of studies by Liu Y. and Wang W et al.
were similar to our results. On the other hand, the results
of studies by Azizieh F, Peterson C.A. and El Hajj C. et al.
were different from our results. We think that this might
be because of the fact that the patient groups in the studies
were different in terms of vitamin D level. Accordingly,
it suggests that as vitamin D deficiency deepens, the
secretion of antiinflammatory cytokines will decrease or
the secretion of proinflammatory cytokines will increase
leading to worsening of inflammation. Furthermore,
it shows that vitamin D can exert its antiinflammatory
effects through immune cells by lowering IL-1β and IL-6
levels.
There was a significant negative correlation between
vitamin D, and adropin level and oxidative stress marker,
TOS, and a significant positive correlation with TAS
(p < 0.05). Antioxidants prevent or remove excessive

endogenous or exogenous free radical production leading
to prevention of free radical-induced cellular damage.
The increased oxidative stress as a result of the shift in
this balance towards the oxidative stress was detected
to play a role in the pathogenesis of various conditions
including metabolic syndrome, endothelial dysfunction,
diabetes mellitus, hypertension, cardiovascular diseases,
malignancy, and kidney and neurological diseases
[14,15,18–20]. In their study in patients with vitamin D
deficiency and healthy controls, Baser H. et al. detected
significant increase in TAS level and significant decrease in
TOS level following vitamin D replacement. Moreover, a
significant positive correlation was found between vitamin
D level TAS, and no significant correlation with TOS [39].
In another study, calcium plus vitamin D supplement for
8 weeks to overweight women with vitamin D deficiency
and PCOS has been detected to have beneficial effects on
inflammatory factor and biological markers of oxidative
stress [40]. In their in vitro study comparing nonenzymatic
antioxidants (Vitamin E, melatonin and beta-estradiol)
with vitamin D, Lin AM. et al. showed that vitamin D
has considerably high antioxidant effect [41]. In a study
on the effect of vitamin D on decreasing oxidative stress
in diabetes mellitus, vitamin D combined with calcium
has been shown to be beneficial in reducing oxidative
stress in rats with streptozotocin-induced diabetes [42].
In their study comparing the plasma levels of several
enzymatic or nonenzymatic antioxidants in 55 diabetic
patients and 40 healthy control subjects, Ramakrishna
V. et al. demonstrated that plasma antioxidant levels are
considerably lower in patients with DM [43]. Adropin
has also been demonstrated to have possible effects on
oxidative stress. In their study on the brains of young
and older rats, Yang C. et al. suggested that adropin level
has negative correlation with endothelial dysfunction
and oxidative damage markers, thereby, adropin loss
in the brain might play a role in the pathogenesis and
development of age-related cerebrovascular dysfunction
[44]. Similar to the other studies, our study shows that the
low level of vitamin D and adropin changes the oxidative/
antioxidative balance in favor of oxidative status (high
TOS, low TAS). Increased oxidative stress in vitamin D
deficiency might be because of reduced synthesis of NO
due to both reduced antioxidant effect of vitamin D and
low adropin level. Furthermore, we think that increased
oxidative stress might have a trigger role in vitamin D
deficiency being a risk factor for many chronic illnesses
and metabolic disorders.
This study has several limitations. First, the number of
patients included is relatively low and it is a single-center
study, and second, it is a female-only study. We think that
the strength of our study is the combined evaluation of
several parameters related with each other.
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5. Conclusions
Significantly decreased adropin levels and significantly
increased levels of proinflammatory cytokines (IL-1β,
IL-6) were detected in vitamin D deficiency with the
oxidative/antioxidative balance being changed in favor of
oxidative status. Vitamin D could show its effects through
vitamin D receptors on tissues via direct or indirect
mechanisms. In addition, it may affect adropin release with
positive or negative effects on the ENHO gene in adropin
secreting tissues. Proinflammatory cytokines, oxidative
stress, and adropin targeted studies could contribute to
the prevention and treatment of diseases associated with
vitamin D deficiency in future. Larger studies are needed
to confirm these results.
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